Esoterix, Inc.
Records under this name other than patents Esoterix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Esoterix, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,163,510 | Quantitative ZAP-70 assay Term ended Ended no later than Oct 14, 2025 · From the USPTO record | Term ended | Ended no later than Oct 14, 2025 | From the USPTO record |
| US 8,828,671 | Simultaneous Assay of Target and Target-Drug Binding Term ended Term ended May 24, 2025 · High confidence | Term ended | Term ended May 24, 2025 | High confidence |
| US 7,943,327 | Simultaneous Assay of Target and Target-Drug Binding Lapsed on the fee record Ended May 17, 2023 · High confidence | Lapsed on the fee record | Ended May 17, 2023 | High confidence |
| US 8,389,224 | Assay for Analysis of Free Drug in Samples Lapsed on the fee record Ended Mar 5, 2021 · High confidence | Lapsed on the fee record | Ended Mar 5, 2021 | High confidence |
| US 6,994,983 | Kits for determination of thromboxane B2 metabolite and optimizing aspirin dosage Term ended Term ended Feb 1, 2021 · From the USPTO record | Term ended | Term ended Feb 1, 2021 | From the USPTO record |
| US 6,905,830 | Tissue analysis and kits therefor Term ended Term ended Jan 31, 2019 · From the USPTO record | Term ended | Term ended Jan 31, 2019 | From the USPTO record |
| US 6,573,043 | Tissue analysis and kits therefor Term ended Term ended Oct 7, 2018 · From the USPTO record | Term ended | Term ended Oct 7, 2018 | From the USPTO record |
| US 6,967,083 | Thromboxane B2 metabolite methods for optimizing aspirin dosage Lapsed on the fee record Ended Nov 22, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2017 | From the USPTO record |
| US 7,326,577 | Cell fixation and use in phospho-proteome screening Lapsed on the fee record Ended Feb 5, 2016 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2016 | From the USPTO record |
| US 7,759,076 | Quantitative ZAP-70 assay Lapsed on the fee record Ended Jul 20, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jul 20, 2014 | From the USPTO record |